Can Lü

750 total citations
24 papers, 535 citations indexed

About

Can Lü is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Can Lü has authored 24 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Can Lü's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (3 papers) and Renal cell carcinoma treatment (2 papers). Can Lü is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (3 papers) and Renal cell carcinoma treatment (2 papers). Can Lü collaborates with scholars based in China, United States and Germany. Can Lü's co-authors include Andrew D. Smith, Riana K. Parvez, Egor Dolzhenko, Meng Li, Pietro E. Cippà, Andrew P. McMahon, Sanjeev Kumar, Jing Liu, Jinjin Guo and Mark C. Dessing and has published in prestigious journals such as Biomaterials, BMC Medicine and Oncotarget.

In The Last Decade

Can Lü

24 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Can Lü China 13 211 105 88 87 79 24 535
Yefei Huang China 15 285 1.4× 84 0.8× 117 1.3× 38 0.4× 56 0.7× 31 563
Ming-Hui Zheng China 16 399 1.9× 68 0.6× 175 2.0× 62 0.7× 67 0.8× 32 684
Lunhao Bai China 14 390 1.8× 42 0.4× 142 1.6× 85 1.0× 77 1.0× 26 741
Hairuo Lin China 12 306 1.5× 78 0.7× 80 0.9× 126 1.4× 43 0.5× 34 642
Bingyan Shu China 7 199 0.9× 101 1.0× 30 0.3× 63 0.7× 150 1.9× 7 489
Ying Miao China 13 161 0.8× 28 0.3× 66 0.8× 43 0.5× 94 1.2× 33 542
Zhipeng Yan China 15 271 1.3× 49 0.5× 64 0.7× 55 0.6× 55 0.7× 23 486
Yasushi Aihara Japan 11 333 1.6× 115 1.1× 56 0.6× 80 0.9× 50 0.6× 17 671
Federica De Zen Italy 10 578 2.7× 203 1.9× 70 0.8× 113 1.3× 217 2.7× 16 920

Countries citing papers authored by Can Lü

Since Specialization
Citations

This map shows the geographic impact of Can Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Lü more than expected).

Fields of papers citing papers by Can Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Lü. The network helps show where Can Lü may publish in the future.

Co-authorship network of co-authors of Can Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Can Lü. A scholar is included among the top collaborators of Can Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can Lü. Can Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Can, Muhammad Tufail, Canhua Jiang, & Ning Li. (2025). Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects. Cancer Cell International. 25(1). 234–234. 1 indexed citations
2.
Liu, Nian, Can Lü, Jie Wu, et al.. (2024). Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1/CCL5 mediated M1 macrophage polarization in melanoma. Biomaterials. 314. 122815–122815. 8 indexed citations
3.
He, Junyan, Zifei Yin, Hui Mu, et al.. (2024). Short-term effects of cupping and scraping therapy for chronic nonspecific low-back pain: A prospective, multicenter randomized trial. Journal of Integrative Medicine. 22(1). 39–45. 4 indexed citations
4.
6.
Wu, Shanshan, et al.. (2023). Single-port endoscopic-sentinel lymph node biopsy combined with indocyanine green and carbon nanoparticles in breast cancer. Surgical Endoscopy. 37(10). 7591–7599. 6 indexed citations
7.
Lü, Can, Jia Li, Jun Li, et al.. (2023). The expression profiles of signature genes from CD103+LAG3+ tumour-infiltrating lymphocyte subsets predict breast cancer survival. BMC Medicine. 21(1). 268–268. 8 indexed citations
8.
Lü, Can, Xiao Peng Zhang, Ulrich Wirth, et al.. (2023). Molecular characteristics of microsatellite stable early-onset colorectal cancer as predictors of prognosis and immunotherapeutic response. npj Precision Oncology. 7(1). 63–63. 17 indexed citations
9.
Lü, Can, Jens Neumann, Ulrich Wirth, et al.. (2023). Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal Cancer. Cancers. 15(19). 4743–4743. 1 indexed citations
10.
Lü, Can, Ulrich Wirth, Jens Neumann, et al.. (2022). Analysis of Circulating Immune Subsets in Primary Colorectal Cancer. Cancers. 14(24). 6105–6105. 4 indexed citations
11.
Lü, Can, et al.. (2022). Identification of CXCL10 and CXCL11 as the candidate genes involving the development of colitis-associated colorectal cancer. Frontiers in Genetics. 13. 945414–945414. 11 indexed citations
12.
Zhao, Tong, et al.. (2021). Aerobic exercise suppresses hepatocellular carcinoma by downregulating dynamin-related protein 1 through PI3K/AKT pathway. Journal of Integrative Medicine. 19(5). 418–427. 23 indexed citations
13.
Liu, Longfei, Xiaoping Yi, Can Lü, et al.. (2021). Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer. Frontiers in Oncology. 11. 658253–658253. 20 indexed citations
14.
Wang, Xin, Wenjuan Song, Yi Ruan, et al.. (2021). Core muscle functional strength training for reducing the risk of low back pain in military recruits: An open-label randomized controlled trial. Journal of Integrative Medicine. 20(2). 145–152. 4 indexed citations
15.
Yang, Shuofei, Zhi‐Chun Gu, Can Lü, et al.. (2019). Neutrophil Extracellular Traps Are Markers of Wound Healing Impairment in Patients with Diabetic Foot Ulcers Treated in a Multidisciplinary Setting. Advances in Wound Care. 9(1). 16–27. 80 indexed citations
16.
Liu, Jing, Sanjeev Kumar, Egor Dolzhenko, et al.. (2017). Molecular characterization of the transition from acute to chronic kidney injury following ischemia/reperfusion. JCI Insight. 2(18). 211 indexed citations
19.
Lü, Can, et al.. (2014). RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation. Acta Pharmacologica Sinica. 35(7). 929–936. 12 indexed citations
20.
Cao, Ke, Peiguo Cao, Qiong Zou, et al.. (2014). SiRNA-Mediated Flotillin-2 (Flot2) Downregulation Inhibits Cell Proliferation, Migration, and Invasion in Gastric Carcinoma Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 21(5). 271–279. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026